Medindia

X

Lupin Gets FDA Approval to Market Generic Irbesartan Tablets in US

by Kathy Jones on  October 18, 2012 at 5:55 PM Drug News   - G J E 4
The US Food and Drug Administration has given approval to Lupin Pharmaceuticals to market its Irbesartan tablets, a generic version of Sanofi Aventis's Avapro, in the country.

The company said that it has received approval to market the Irbesartan tablets in 75-300 mg strengths.
 Lupin Gets FDA Approval to Market Generic Irbesartan Tablets in US
Lupin Gets FDA Approval to Market Generic Irbesartan Tablets in US
Advertisement

The Avapro tablets are used in treating hypertension and nephropathy in type II diabetic patients and accounted for more than $400.7 million in annual sales, according to data from IMS health.


Advertisement
Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All

More News on: